Author(s)

Michael T. Nelson, Sina Meisamy

Department of Radiology, University of Minnesota Medical School Minneapolis, MN, USA.

Motiva Implants® (Establishment Labs Holdings Inc., NY, USA) contains a RFID micro transponder RFID^(RT) (RT = registered trademark) known as Q Inside Safety Technology which provides an added safety feature embedded in the shell of the Motiva breast implant [1] [2]. Because this RFID micro transponder has Ferric components, a concern over breast MRI imaging susceptibility artifact has arisen. Among breast images, a single high risk breast cancer patient was imaged at our institution (January 2018). All breast imaging modalities were used to determine if this high risk patient had a recurrence of her cancer or any new breast cancer. The MRI showed a susceptibility artifact on the posterior margin of the implant but breast ultrasound showed no abnormalities in the area of the susceptibility artifact. By using high risk screening including Mammography, Tomosynthesis, Breast Ultrasound and Breast MRI, an adequate survey of the high risk patient was completed [3]. Our high risk clinic examined the patient and the imaging results and came to the following conclusion: This patient showed no evidence of recurrent cancer and no new masses were identified. The conclusion was BIRADS 2 benign: normal findings post-mastectomy and implants. Recommendation was for routine high risk screening at yearly interval.

Breast MRI, Ultrasound, Mammography Implants, Radiofrequency Identification Device [RFID]

Nelson, M. and Meisamy, S. (2019) High Risk Breast Cancer Patient with Silicone Breast Implant and Q Inside SafetyTM Micro Transponder. Open Journal of Medical Imaging, 9, 52-57. doi: 10.4236/ojmi.2019.94005.